✦ LIBER ✦

Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S-303 pathogen inactivation treatment

✍ Scribed by Anne North; Vic Ciaravino; Nina Mufti; Laurence Corash

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Viability of red cells prepared with S-3

✍ Jorge A. Rios; Julie Hambleton; Maurene Viele; Neeta Rugg; Gail Sindermann; Tibo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Stored red blood cell viability is maint

✍ Jose A. Cancelas; Larry J. Dumont; Neeta Rugg; Zbigniew M. Szczepiorkowski; Loui 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 590 KB

Treatment of whole blood (WB) and red bl

✍ N.A. Mufti; A.C. Erickson; A.K. North; D. Hanson; L. Sawyer; L.M. Corash; L. Lin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 151 KB

PHM4 COST-EFFECTIVENESS OF TRANSFUSING B

✍ U Staginnus; S Russell 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PBR4 COST-EFFECTIVENESS OF TRANSFUSING B

✍ U Staginnus; S Russell; LM Corash 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Therapeutic efficacy and safety of red b

✍ Richard J. Benjamin; Jeffrey McCullough; Paul D. Mintz; Edward Snyder; William D 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 109 KB